|
| | Publication Year | Title | Author(s) |
| 1 | 24-Dec-2009 | Neurolymphomatosis: diagnosis, management, and outcomes in patients treated with rituximab. | Gan, Hui K ; Azad, Arun A; Cher, Lawrence M ; Mitchell, Paul L R |
| 2 | 1-May-2008 | A phase II study of liposomal daunorubicin, in combination with cyclophosphamide, vincristine and prednisolone, in elderly patients with previously untreated aggressive non-Hodgkin lymphoma. | Mitchell, Paul L R ; Marlton, Paula; Grigg, Andrew P ; Seymour, John F; Hertzberg, Mark; Enno, Arno; Herrmann, Richard; Bond, Rodney; Arthur, Chris |
| 3 | 21-May-2007 | Prevalence of occult metastatic disease in patients undergoing 18F-FDG PET for primary diagnosis or staging of lung carcinoma and solitary pulmonary nodules. | Lee, S T; Berlangieri, Salvatore U ; Poon, A M T; Mitchell, Paul L R ; Pathmaraj, K ; Tabone, K; Byrne, Amanda J; O'Keefe, Graeme J; Knight, Simon R ; Clarke, C Peter; Scott, Andrew M |
| 4 | 1-Jul-2006 | Addition of gabapentin to a modified FOLFOX regimen does not reduce oxaliplatin-induced neurotoxicity. | Mitchell, Paul L R ; Goldstein, David B; Michael, Michael; Beale, Philip; Friedlander, Michael; Zalcberg, John; White, Shane C; Thomson, Jacquelyn A; Clarke, Stephen |
| 5 | 1-Feb-2006 | Mannan-MUC1-pulsed dendritic cell immunotherapy: a phase I trial in patients with adenocarcinoma. | Loveland, Bruce E; Zhao, Anne; White, Shane C; Gan, Hui K ; Hamilton, Kate ; Xing, Pei-Xiang; Pietersz, Geoffrey A; Apostolopoulos, Vasso; Vaughan, Hilary A; Karanikas, Vaios; Kyriakou, Peter; McKenzie, Ian F C; Mitchell, Paul L R |
| 6 | 1-Jul-2004 | Positron emission tomography scanning in the assessment of patients with lymphoma. | Foo, S S; Mitchell, Paul L R ; Berlangieri, Salvatore U ; Smith, C L; Scott, Andrew M |
| 7 | 17-May-2004 | Austin Bowel Cancer Consortium: changing culture in bowel cancer care. | Mitchell, Paul L R ; White, Craig A |
| 8 | 1-Apr-2004 | A phase II study of escalated-dose docetaxel with granulocyte colony-stimulating factor support in patients with advanced breast cancer. | Mitchell, Paul L R ; Basser, R L; Chipman, M; Grigg, Andrew P ; Mansfield, R; Cebon, Jonathan S ; Davis, Ian D; Appia, F; Green, M |
| 9 | 1-Jul-2003 | Targeting primary human Ph(+) B-cell precursor leukemia-engrafted SCID mice using radiolabeled anti-CD19 monoclonal antibodies. | Mitchell, Paul L R ; Lee, Fook-Thean; Hall, Cathrine; Rigopoulos, Angela; Smyth, Fiona E; Hekman, Anne-Marie; van Schijndel, Gijs M; Powles, Ray; Brechbiel, Martin W; Scott, Andrew M |
| 10 | 1-May-2003 | A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer. | Scott, Andrew M ; Wiseman, Greg; Welt, Sydney; Adjei, Alex; Lee, Fook-Thean; Hopkins, Wendie; Divgi, Chaitan R; Hanson, Lorelei H; Mitchell, Paul L R ; Gansen, Denise N; Larson, Steven M; Ingle, James N; Hoffman, Eric W; Tanswell, Paul; Ritter, Gerd; Cohen, Leonard S; Bette, Peter; Arvay, Lisa; Amelsberg, Andree; Vlock, Dan; Rettig, Wolfgang J; Old, Lloyd J |
Loading...
2
0
20
0
false